Fig. 4From: Pathogen-based target attainment of optimized continuous infusion dosing regimens of piperacillin-tazobactam and meropenem in surgical ICU patients: a prospective single center observational studyPercentage of samples above the toxicity threshold for TZP according to renal function on day of samplingBack to article page